Notably, CD103+CD8+ TRM cells exhibited a higher number and diversity of predicted ligand–receptor interactions compared to CD103−CD8+ T cells, indicating a more active role in modulating the tumour microenvironment (Figure S4G). Here, CD8A is linked to neoplasm.